ArticleAsian Pacific journal of cancer prevention : APJCP2021

Anticancer Effect of Rh2, a Histone Deacetylase Inhibitor, in HepG2 Cells and HepG2 Cell-Derived Xenograft Tumors Occurs via the Inhibition of HDACs and Activation of the MAPK Signaling Pathway.

Shi Qing Qiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.